Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Long-term steroid use is known to increase the risk of conditions that weaken the bones in the body. A new study, published in the European Respiratory Journal, looked at the risk specifically for people with asthma who use steroids to help ease asthma symptoms, such as breathlessness and coughing.
What did the study look at?
The authors aimed to understand the risk of two types of bone conditions:
This study used a research database containing health information about millions of people from doctors’ practices in the UK. The authors searched for people with asthma and compared them to people without asthma. In addition to looking at cases of osteoporosis and fractures, they also looked at the use of steroids.
What do the results show?
People with asthma were found to have a higher risk of osteoporosis. The risk of fracture was also higher in the group of people with asthma – 3.1% of people with asthma (31 in every 1,000 people) sustained a fracture, compared to 2.5% of people without asthma (25 in every 1,000 people).
The results also found that the risk of fracture was increased with even just one prescription of steroids each year. Increasing the number of prescriptions of steroids each year also appeared to raise the risk of osteoporosis. The risk was larger for young people with asthma, compared to young people without asthma.
Why is this important?
The findings are important to help people understand more about the medication they are taking. The authors suggest that healthcare professionals can help to reduce the risk of these bone conditions for people with asthma by reviewing steroid use and using the lowest dose possible.
Title: Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study
https://erj.ersjournals.com/content/early/2020/08/03/13993003.01251-2020
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79